PATENT CLAIM ANALYSIS

Application Number: 16224140
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["540", "456000"]

Abstract:
The present invention provides methods for obtaining purified rapamycin derivatives, including purified Biolimus A9. A crystalline form of Biolimus A9 is also described.

Claim (Index 34):
The method of  claim 33 , wherein the non-polar organic solvent is selected from the group consisting of hexane, heptane, methyl t-butyl ether, ligroin, octane, cyclohexane, and mixtures thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.18182
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14853711', '15422593', '14804714', '16197037', '13497416']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7237731928434629
- 35 USC 102 Novelty (BERT): 0.5430860388416798
- Combined Prediction Score: 0.7057044774432846
- Mean Citation Score: 263.926648
- Max Citation Score: 383.7347
- Similarity Product: 314.7988849452376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test